Tracking hard-to-treat bacteria in ICU and transplant patients
Part of Immune system & allergy, Infections clinical trials.
This study will track how certain hard-to-treat bacteria spread and cause infections in people who are in the intensive care unit (ICU) or have had a stem cell transplant. The goal is to better understand and prevent these infections in vulnerable patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been admitted to an intensive care unit (ICU) or a stem cell transplant unit in the past 24 hours.
- You are 18 years old or older.
- You are not pregnant.
- You do not have a history of inflammatory bowel disease (like Crohn's disease or ulcerative colitis).
- You do not have a colostomy, ileostomy, or other gastrointestinal derivation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving vancomycin through a tube into the stomach can prevent a serious gut infection called C. diff in people who are very sick in the ICU and taking antibiotics. If you qualify, you might receive this medicine to lower your risk.
This trial studies whether cefiderocol plus ampicillin-sulbactam works better than colistin (sometimes with meropenem) for serious infections caused by carbapenem-resistant Acinetobacter baumannii (a hard-to-treat germ). It may help by finding a more effective antibiotic plan for people with these severe hospital-acquired infections.
This study looks at certain drug-resistant bacteria in the gut of ICU patients. It aims to understand how common these bacteria are and may help guide future infection control efforts.
This study validates a prediction tool designed to identify which ICU patients are at risk of developing multidrug-resistant gram-negative bacteria (a serious infection resistant to many antibiotics). The tool may help doctors start appropriate treatment earlier and improve patient outcomes.
This study monitors how antibiotics behave in the body for ICU patients being treated for sepsis or septic shock. It aims to learn whether better monitoring can support safer, more effective antibiotic use.
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
Hear when a new Antimicrobial Drug Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.